List of Excipients in API ZANUBRUTINIB
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ZANUBRUTINIB
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
BEIGENE USA INC | BRUKINSA | zanubrutinib | 72579-011 | CELLULOSE, MICROCRYSTALLINE | 2037-08-15 |
BEIGENE USA INC | BRUKINSA | zanubrutinib | 72579-011 | CROSCARMELLOSE SODIUM | 2037-08-15 |
BEIGENE USA INC | BRUKINSA | zanubrutinib | 72579-011 | FERROSOFERRIC OXIDE | 2037-08-15 |
BEIGENE USA INC | BRUKINSA | zanubrutinib | 72579-011 | GELATIN | 2037-08-15 |
BEIGENE USA INC | BRUKINSA | zanubrutinib | 72579-011 | MAGNESIUM STEARATE | 2037-08-15 |
BEIGENE USA INC | BRUKINSA | zanubrutinib | 72579-011 | SILICON DIOXIDE | 2037-08-15 |
BEIGENE USA INC | BRUKINSA | zanubrutinib | 72579-011 | SODIUM LAURYL SULFATE | 2037-08-15 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ZANUBRUTINIB
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ZANUBRUTINIB drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
BEIGENE USA INC | zanubrutinib | 72579-011 |
>Company | >Ingredient | >NDC |
ZANUBRUTINIB drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
ZANUBRUTINIB drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
BEIGENE USA INC | zanubrutinib | 72579-011 |
>Company | >Ingredient | >NDC |
ZANUBRUTINIB drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
ZANUBRUTINIB drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
BEIGENE USA INC | zanubrutinib | 72579-011 |
>Company | >Ingredient | >NDC |
ZANUBRUTINIB drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
ZANUBRUTINIB drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
BEIGENE USA INC | zanubrutinib | 72579-011 |
>Company | >Ingredient | >NDC |
ZANUBRUTINIB drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ZANUBRUTINIB drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
BEIGENE USA INC | zanubrutinib | 72579-011 |
>Company | >Ingredient | >NDC |
ZANUBRUTINIB drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
ZANUBRUTINIB drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
BEIGENE USA INC | zanubrutinib | 72579-011 |
>Company | >Ingredient | >NDC |
ZANUBRUTINIB drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
ZANUBRUTINIB drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
BEIGENE USA INC | zanubrutinib | 72579-011 |
>Company | >Ingredient | >NDC |
ZANUBRUTINIB drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ZANUBRUTINIB drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
BEIGENE USA INC | zanubrutinib | 72579-011 |
>Company | >Ingredient | >NDC |
ZANUBRUTINIB drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.